Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 6Ovarian Neoplasms 5Colorectal Neoplasms 5Pancreatic Neoplasms 4Neoplasm Metastasis 4Fallopian Tube Neoplasms 4Multiple Myeloma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Primary Myelofibrosis 2Neoplasms 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Glioblastoma 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1

Interventions

Paclitaxel 8Carboplatin 8Taxes 6Topotecan 3Cisplatin 3Bevacizumab 3SS1(dsFv)PE38 2Filgrastim 2Etoposide 2veliparib 1trioctyl phosphine oxide 1paclitaxel poliglumex 1VTX-2337 1Thiotepa 1Reverse Transcriptase Polymerase Chain Reaction 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Docetaxel 1Disulfides 1Chemotherapy, Adjuvant 1Bortezomib 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Brenner Tumor × Disulfides × Clear all
NCT00989651 2021-10-20

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 1 Completed
431 enrolled
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡